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Endovascular reconstruction of the tibial arteries is assuming
a larger role in limb salvage.1e3 The infrageniculate vascular
bed has required mostly open surgery in the past, with distal
vein bypass being the most common procedure. Disease in
the tibial arteries tends to be diffuse and is usually
a combination of long segment stenoses or occlusions. The
small caliber of the arteries, the remote location, the slow
flow of the distal bed, and concerns about preserving runoff
capacity have combined to make this a vascular bed that
presents challenges to endovascular treatment. Recent
advances have enhanced our ability to use endovascularXXIII Annual meeting 3e6
ascular Surgery,Oslo,Norway.
f Vascular Therapy, Hawaii
t White Road, Honolulu, HI
@aol.com (P.A. Schneider).
lsevier Ltd on behalf of Europeanprocedures to treat critical limb ischemia (CLI) caused by
tibial artery occlusive disease. Improved sheaths have been
developed as a result of the routine use of remote access to
other vascular beds, such as the carotid system. Low profile
platforms are essential in treating small caliber arteries and
are being adapted to the infrageniculate vascular bed. Long
balloons are used to treat lengthy segments of disease and
this has helped to reduce dissection. Better antiplatelet
options have been developed for the coronary and carotid
beds and are being used for tibial interventions. Small
caliber stents are available in both balloon expandable and
self-expanding varieties, and there are several studies that
will add to our understanding of their potential uses.4
Improved devices and techniques have lead to increased
aggressiveness in the endovascular treatment of the infra-
geniculate vascular bed for critical limb ischemia.
Indications
Tibial angioplasty and stenting is appropriate for limb
salvage, especially when there is focal tibial diseaseSociety for Vascular Surgery.
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date or a patient with no venous conduit is also reasonable.
Whether endovascular tibial reconstruction is appropriate
as first line treatment in all patients remains to be proven
in randomized trials with long-term follow up. Surgery
remains the gold standard by which endovascular inter-
ventions are measured and is still favored for appropriate
surgical candidate.8
The results of tibial angioplasty and stenting are closely
tied to the degree of foot damage with which the patient
presents. When foot damage is in an early stage, a small
improvement in perfusion may be enough to heal the
lesion, even if patency is only short term. The best results
are achieved when presenting ischemic foot damage is
minimal; risks of intervention are low, the likelihood of
damaging the runoff is low, and a leg bypass is often avoi-
ded. When there is objective evidence of ischemia and an
open ischemic lesion that has caused minimal damage,
endovascular is the treatment of choice, rather than
waiting to see if the patient needs a distal bypass.
Unfortunately, many patients present with severe foot
damage, often with ongoing or partially treated infection.
When foot damage is extensive, recanalizing one tibial
artery is often not adequate for limb salvage. The goal is to
open as many tibial arteries as possible to provide robust in-
line flow to a severely damaged foot. If the only target is an
isolated segment that does not provide in-line flow to the
foot, don’t waste time with endovascular. If there is
significant disease at a more proximal level, in the iliac or
femoro-popliteal segments, and the foot damage is minor,
treat those inflow lesions first and wait to see what the
clinical effect will be, especially if tibial disease appears to
be high risk.
When revascularization is performed, the mainstay of
therapy is balloon angioplasty. Because distal disease is
usually diffuse throughout these small caliber flexible
arteries, stents are not ideal and are used sparingly. Other
options for tibial artery revascularization, such as cry-
oplasty and laser or mechanical atherectomy, remain to be
proven.Figure 1 Early intervention is key, more important than long-ter
peroneal artery before and after balloon angioplasty.Results
A number of articles and studies have been published since
1990 demonstrating the utility of endovascular angioplasty
in treatment of critical limb ischemia. The Bypass versus
Angioplasty in Severe Ischemia of the Leg (BASIL) trial was
published in 2005.5 This was a prospective randomized trial
of 452 patients comparing patients treated with bypass-
surgery-first and balloon angioplasty-first. They found no
significant difference between the two arms with respect to
amputation-free survival at three years. The majority of
the patients in the angioplasty group (80%) had lesions of
the SFA treated, and 62% of patients in the surgery group
underwent more distal bypass. Long-term follow up and
subgroup analysis suggest that surgery is still the best
option for fit patients with adequate venous conduit for
bypass, though they report a decline in the numbers of
operative procedures due to improved medical and endo-
vascular interventions.8
Faglia et al. evaluated angioplasty-first in diabetic
patients with CLI.6 In their group of 993 patients, 31.8% had
lesions of the infrapopliteal axis alone and 61.4% had
lesions in the femoral-popliteal and infrapopliteal
segments. The majority of patients underwent balloon
angioplasty of multiple vessels, with success rates for PTA
of popliteal and proximal vessels being significantly higher
than for PTA of infrapopliteal vessels. Regardless, primary
patency of the successfully treated vessels at 5 years was
88% and limb salvage was achieved in more than 98% of
patients.
A recent meta-analysis of 30 articles by Romiti et al.
looked at immediate technical success, primary and
secondary patency, limb salvage, and survival for patients
treated with infrapopliteal percutaneous transluminal
angioplasty (PTA).7 These were compared to similar end
points for patients treated with vein bypass grafts. The
meta-analysis showed tissue loss and diabetes correlated
with outcome (P < 0.002). There a significant difference in
patency rates between vein bypass and PTA, but limb
salvage rates were similar up to three years (Table 1).m patency. Shown here is a tibioperoneal trunk occlusion and
Table 1 Comparison of primary patency and limb salvage
of angioplasty vs. vein bypass, modified from Romiti et al.7
Results 1 month 1 year 3 years
Primary patency
PTA 77.4 4.1% 58.1 4.6% 48.6 8.0%
Bypass 93.3 1.1% 81.5 2.0% 72.3 2.3%
Limb salvage
PTA 93.4 2.3% 86.0 2.7% 82.4 3.4%
Bypass 95.1 1.2% 88.5 2.2% 82.3 3.0%
Figure 2 The sheath tip should be placed as close to the
lesion as possible. Shown here is the sheath tip in the tibio-
peroneal trunk.
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Technical tips are provided here about sheath access,
lesion crossing and guidewire access, balloon angioplasty,
stenting, and mangaging occlusions.
Sheath access
Patients are pretreated with clopidogrel. As soon as arterial
access is achieved, heparin is administered. In treating
complex tibial artery occlusive disease, heparin is admin-
istered at 100 units per kg and activated clotting time is
assessed and maintained at >250 s.
Angiography is performed with an up and over approach.
If there is excessive difficulty with passage across the aortic
bifurcation, it will become readily apparent during this
simple procedure. It is difficult to plan a below the knee
intervention in its entirety without an angiogram. Duplex,
CT angiograms and MR angiograms are helpful, but a stan-
dard catheter-based angiogram is needed prior to inter-
vening. The arteriogram typically influences the final
choice of procedure. In general, we plan up front to
perform vascular closure, unless some reason becomes
apparent why closure should not be done. If an angiogram is
performed initially with an antegrade approach and then
the operator decides not to intervene, you are stuck with
a puncture site that must be managed, and now it is
proximal to a segment that may thrombose when pressure
is held proximally. After the lesion is assessed and the
decision is made to intervene, the distance from the
puncture site to the lesion is measured.
In most patients, the sheath can usually be placed in the
contralateral femoral artery allowing access to the mid-
tibial level. A 90 cm sheath reaches at least to the
contralateral popliteal artery in most people who are 5 foot
10 inches or less. In very tall individuals, a 90 cm sheath
may reach only the mid-superficial femoral artery. If the
plan is to treat the distal tibial, ankle or pedal arteries, an
antegrade femoral approach should be considered. An
antegrade approach should also be considered when the
aortic bifurcation is so unfriendly that it is risky to use as
a pathway, such as when it is aneurysmal or very narrow,
heavily calcified, or very tortuous.
Aftermeasuring thedistance to the lesion, the sheathmust
be selected. If the plan is to go up and over the aortic bifur-
cation but the aortic bifurcation is tortuous, it is occasionally
helpful to place a 7 Fr sheath (45 cm in length) over the aortic
bifurcation and then place a smaller caliber sheath (5 Fr)
through it. Usual sheath lengths are as follows. Up and overinterventions can be performed with a 70 cm sheath, a 90 cm
sheath or a 110 cm sheath. Antegrade interventions can be
performed with a 55 cm or 70 cm sheath. If there is a lot of
distal SFA disease or popliteal disease, place the sheath tip
proximal to that level of disease.
Most tibial interventions can be performed with 5 Fr
sheaths. This permits balloon angioplasty and stents. If the
operator selects cryoplasty or atherectomy, a larger caliber
sheath will be required, 6 or 7 Fr. There are no stents
approved for tibial interventions but the available appro-
priately sized self-expanding and balloon expandable stents
are possible to place through a 5 Fr sheath. A larger sheath
may be used, but if it is intended to place the tip of the
sheath into the popliteal artery, the size of the larger
caliber sheath may stop flow in this area and that may
present other problems.
Place the tip of the sheath as close to the lesion as possible
(Fig. 2). When disease is isolated to the tibial arteries, the tip
of the sheathcanbeplaced in thebelowkneepopliteal artery.
If a 4 Fr sheath is used, the tip can be placed directly into the
tibial artery to be treated. If the patient has a more proximal
lesion that requires treatment in the same procedure, such as
a superficial femoral artery stenosis or occlusion, that is
treated first and the sheath is advanced through the treated
lesion to get closer to the tibial arteries. All this work of
optimal sheath placement pays off: this permits better push-
ability with 3 Fr monorail catheters, less contrast, faster
results, better support, less effort.
Sheaths are available in the range of 50e90 cm in length.
In addition, now there is a 110 cm sheath that comes in
either 4 or 5 Fr caliber that may be used. Place the diag-
nostic catheter during the arteriogram and use it to esti-
mate the desired length of the sheath. When passing the
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it may cause damage. Keep the stiff guidewire in the
popliteal artery. Place the sheath as far as possible with the
exchange guidewire in the popliteal artery. If there is any
excess length outside the patient and the sheath can be
advanced an additional length toward the tibial artery
origin, place a catheter fitted to the sheath into the tibial
over a softer wire (either 035 or 014). Hold the catheter
stable and advance the sheath over the catheter and
guidewire combination.
Crossing Lesion/Guidewire Access
After the sheath is in place, a 0.014 in diameter guidewire
is advanced. I like to use a steerable, soft guidewire.
A 300 cm length guidewire is preferred. Even though
monorail systems are employed when possible, a longer
guidewire is used because the exchange catheters, such as
the Quickcross, and some of the stent delivery catheters,
such as the Xpert, are coaxial platforms. The guidewire tip
should be angled into a hockey stick shape. The tibial artery
origin is roadmapped. The guidewire may be supported by
a long 4 Fr Glidecath (up to 120 cm length with angled tip).
A Tuohy-Borst adapter is placed on the hub. The catheter is
angled toward the appropriate tibial artery and the guide-
wire is advanced. The catheter is advanced into the origin
of the tibial artery to support the guidewire. The guidewire
is advanced to just above the lesion (Fig. 3). The tibial
artery lesion is placed on a magnified field of view. Contrast
is administered through the catheter so that the tibial
artery will be well delineated, even if flow in it is very slow.
Vasodilator may be administered through the catheter into
the tibial artery. If there is an occlusion or the suggestion
that thrombus is present in the tibial artery, thrombolytic is
administered.Figure 3 The sheath is introduced as close as possible to the lesi
into the appropriate artery. (a) demonstrates the placement of the
Angiogram of a proximal peroneal stenosis before (b) and after (c)Several different oblique projections may be required to
see the lesion in its best angle for guidewire passage, and
adjust the image so that an important part of the lesion is
not superimposed onto a bony cortex that would diminish
the quality of the image. The guidewire is advanced
deliberately and collaterals are avoided. After the guide-
wire is across the lesion, it is placed well distal to the
lesion. The guidewire may be exchanged for a stiffer one if
stability is an issue. The 4 Fr catheter can be advanced. If
this will not pass because the lesion is too tight or the
catheter is not long enough, a Quickcross catheter (either
.014 or .018) may be used to pass over the guidewire and
function as an exchange catheter.
Balloon angioplasty
Low profile monorail or coaxial balloon angioplasty catheters
may be used. Monorail systems are faster and simpler to
advance but only work well when the sheath tip can be
placed close to the lesion as described above. Balloons are
available from 2 to 12 cm in length and from 1.5 to 4 mm in
diameter. The shaft length varies from 120 to 150 cm. The
length of the balloon catheter should be assessed prior to
insertion because there is some limitation to how far it
reaches from an up and over approach. The contralateral
ankle is out of reach in some patients, even with a 140 or
150 cm catheter. When approaching a lesion from the
contralateral side, pushability becomes very poor when
reaching toward the distal tibial and ankle. This is worsened
by the fact that a long length of guidewire cannot be placed
beyond the lesion since the foot is so close. If the long
balloon catheter won’t advance, take the time to place
a stiffer guidewire, such as an Iron man or a Confianza.
Focal tibial artery lesions of 1.5 cm or less may be
treated with cutting balloon angioplasty. Longer lesions oron and a glide catheter is used to direct a steerable guidewire
sheath and catheter to support advancement of the quidewire.
balloon angioplasty.
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long tibial balloons. Do your best to choose a single balloon
that just exceeds the length of the lesion. An external
marker is good for this and marker guidewires are also
available. Compliant balloons come in a variety of sizes
and the diameter can be dialed up to match the appro-
priate size of the normal proximal or distal artery on
roadmapping. Oversizing the angioplasty balloon does not
seem to be helpful. A single inflation at the desired pres-
sure is performed and then maintained for 3 min. Anti-
coagulation is maintained while the artery is occluded. If it
seems likely that the balloon will require more than one
inflation because the lesion is too long, treat the distal
lesion first. After the balloon is deflated, it will be easier
to withdraw than to advance. A slow, deliberate, extended
balloon inflation in only one location offers the lowest
chance of dissection. After angioplasty, the balloon is
withdrawn into the sheath, but does not need to be
removed. If you decide to perform angioplasty again, the
balloon will be ready.
A completion arteriogram is performed. If a significant
dissection or an occlusion is present, repeat the angioplasty
to slightly higher pressure. Make sure anticoagulation is
adequate. Consider administering thrombolytic agent if
there is an occlusion. An aspiration catheter, such as an
Export catheter, may also be passed. Stents are generally
avoided when possible but, at some point, if the dissection
or the occlusion is not improved, consider placing a stent.
Stenting
Significant dissection that cannot be resolved with balloon
angioplasty should be treated with stent placement.
Available stents include coronary stents which are
short (usually 15 mm or less) and balloon expandable.
Self-expanding nitinol stents are available in small sizes
(2e5 mm; Abbott Xpert). These are coaxial so a longer
guidewire is required and are 4 Fr compatible. For tibialFigure 4 Shown here is an occlusive lesion with distal reconstitut
advance a guidewire into the distal reconstituted artery (c).artery origin lesions, balloon expandable stents are desired
because of accuracy of placement. Self-expanding stents
are longer, more flexible, and are better suited to the tibial
arteries distal to the origin. Because of the remote loca-
tion, the stent deployment process is influenced by
a number of forces causing extra play in the system.
Therefore the process is performed carefully under
magnified fluoroscopic observation. After stent placement,
post-stent balloon angioplasty is performed to seed the
stents. The patient must be warned to avoid future blood
pressure cuff inflation on the leg.
Managing occlusions
Enter the tibial artery as described above. Place aQuickcross
.018 catheter (Fig. 4). Through the catheter, place a V18
Control wire (Boston Scientific). Push the V18 guidewire into
the occlusion. Push as far as it goes easily. When it stops,
push the Quickcross catheter. Sometimes the catheter will
go on its own. It has markers on the tip and is relatively stiff.
It can be used with the guidewire in a ‘‘hopscotch’’ manner.
Don’t try to form a loop with the tip of the wire as is done for
subintimal angioplasty in the femoro-popliteal segment.
After crossing the occlusion, sometimes it is difficult to get
contrast to go into the artery distal to the occlusion to
confirmguidewire positioning. Administer nitroglycerine and
perform delayed imaging. After crossing the occlusion,
perform balloon angioplasty as you would have if it were
a stenosis. Be careful with the stiff tip on the V18 wire.
Discussion
Ouralgorithmfor treating infrapopliteal lesions that causeCLI
is shown in Fig. 5. If adequate inflow can be established by
treating a more proximal lesion and the foot damage is
minimal, treat the inflow and follow the patient closely with
duplexand clinical exam. If the foot damage ismajor, treat allion (a) A Quickcross catheter is used to cross the lesion (b) and
Figure 5 Treatment algorithm for critical limb ischemia by tibial artery occlusive disease.
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be major and the runoff in that limb is poor, consider bypass
first in that group: this is approximately 20% of the patients in
ourpractice.When tibial intervention is indicated, determine
if the lesion is focal or diffuse. PTA using a short coronary
balloon or a cutting balloon is performed for focal lesions.
Longer lesionsmay requireeither a long, lowprofileballoonor
plaquedebulking (weuse theexcimer laser). If there is severe
dissection that cannot be resolved with repeat balloon infla-
tion,considerplacementofabaremetal ordrugeluting stent.
Conclusion
Endovascular reconstruction of infrapopliteal lesions in
critical limb ischemia is a reasonable and effective approach
in the appropriately chosen patient. Choosing the best
access for below the knee interventions is instrumental in
setting the operator up for success and subsequent posi-
tioning of an adequate sized sheath with the tip close to the
lesion is an essential maneuver. The techniques described
here are a guide to approaching distal lesions in patients with
critical limb ischemia. This field will continue to evolve as
advances are made in stent and instrument technology and
may achieve parity with open bypass procedures.
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